Pioneering Biological Artificial SuperIntelligence
About Owkin
Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology too challenging for human researchers alone.
Owkin builds K Pro - an AI scientist that works alongside pharmaceutical research teams to power discovery and strategic decision-making. K Pro autonomously orchestrates a suite of AI skills and tools to decode complex biology and accelerate research, with scientists shaping every hypothesis, decision, and discovery.
K Pro is built on Owkin’s unrivalled multimodal patient data network, state-of-the-art AI for biology, and a decade of experience working hand-in-hand with pharmaceutical partners.
What we believe
Automating early R&D with one autonomous AI Scientist
Founded in 2016 by a clinical oncologist and a machine learning pioneer, Owkin was built on a single conviction: AI applied to multimodal patient data should do science, not just support it.
Today, K Pro brings together biological large language models, multimodal patient data, and a decade of biomedical AI expertise into one AI Scientist to enable smarter, faster drug discovery decisions.
Our ambition goes further. We are working towards biological artificial superintelligence: an autonomous, self-improving AI Scientist that exceeds human performance across all life science domains and is capable of running large parts of drug discovery on its own.
Why work with Owkin
Sanofi - AI drug discovery
BMS - AI drug development
MSD - AI diagnostics
Learn more about what we do
Owkin's AI Scientist
We are developing the autonomous AI Scientist for biology, closing the loop from patient data to validated molecules.
The AI agent for biology, powered by multimodal patient data, for smarter biopharma decision making.
